| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 7.63e-18 | 26 | 28 | 8 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.59e-15 | 52 | 28 | 8 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | SCN10A KCNE2 PIEZO2 PKD1L2 PKDREJ SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.30e-14 | 343 | 28 | 12 | GO:0005261 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.37e-14 | 465 | 28 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SCN10A SLC6A7 SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.87e-14 | 171 | 28 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 4.61e-14 | 664 | 28 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 ABCA6 PKDREJ SLC9C2 ABCA8 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 3.11e-13 | 1180 | 28 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | SCN10A KCNE2 PIEZO2 PKD1L2 PKDREJ SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 4.11e-13 | 459 | 28 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 5.19e-13 | 793 | 28 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 6.20e-13 | 627 | 28 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | transporter activity | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 ABCA6 PKDREJ SLC9C2 ABCA8 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.21e-12 | 1289 | 28 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | SCN10A KCNE2 PIEZO2 PKD1L2 PKDREJ SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 2.00e-12 | 525 | 28 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SCN10A KCNE2 PIEZO2 PKD1L2 PKDREJ SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 2.04e-12 | 526 | 28 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 6.79e-12 | 758 | 28 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium ion binding | 7.38e-12 | 14 | 28 | 5 | GO:0031402 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 2.40e-10 | 26 | 28 | 5 | GO:0031420 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.66e-06 | 17 | 28 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 2.83e-05 | 6 | 28 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.10e-05 | 334 | 28 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.15e-04 | 182 | 28 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.20e-04 | 184 | 28 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.83e-04 | 230 | 28 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 1.76e-03 | 172 | 28 | 3 | GO:0044325 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.14e-03 | 49 | 28 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.18e-03 | 477 | 28 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.02e-02 | 109 | 28 | 2 | GO:0042626 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.21e-17 | 62 | 28 | 9 | GO:0086002 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.13e-16 | 36 | 28 | 8 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.79e-15 | 87 | 28 | 9 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.33e-15 | 93 | 28 | 9 | GO:0086003 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.41e-14 | 63 | 28 | 8 | GO:0019228 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.97e-14 | 127 | 28 | 9 | GO:0070252 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SCN10A SLC6A7 SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 9.81e-14 | 208 | 28 | 10 | GO:0035725 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 3.28e-13 | 153 | 28 | 9 | GO:0030048 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 7.28e-13 | 167 | 28 | 9 | GO:0060048 | |
| GeneOntologyBiologicalProcess | sodium ion transport | SCN10A SLC6A7 SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.60e-12 | 275 | 28 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.66e-12 | 112 | 28 | 8 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 WFS1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 2.94e-12 | 1157 | 28 | 15 | GO:0006812 |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.13e-12 | 121 | 28 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 3.45e-12 | 942 | 28 | 14 | GO:0098655 |
| GeneOntologyBiologicalProcess | action potential | 3.90e-12 | 201 | 28 | 9 | GO:0001508 | |
| GeneOntologyBiologicalProcess | metal ion transport | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 WFS1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 7.70e-12 | 1000 | 28 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 7.77e-12 | 217 | 28 | 9 | GO:0006941 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 3.30e-11 | 1115 | 28 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SCN10A SLC6A7 KCNE2 PIEZO2 PKD1L2 PKDREJ SLC9C2 WFS1 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 3.44e-11 | 1374 | 28 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 5.25e-11 | 922 | 28 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | heart contraction | 1.32e-10 | 298 | 28 | 9 | GO:0060047 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SCN10A SLC6A7 KCNE2 PKD1L2 PKDREJ SLC9C2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.77e-10 | 1017 | 28 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | heart process | 1.82e-10 | 309 | 28 | 9 | GO:0003015 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 6.66e-10 | 75 | 28 | 6 | GO:0050982 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | SCN10A KCNE2 PIEZO2 SCN1A SCN2A SCN3A SCN4A SCN5A SCN8A SCN9A | 1.67e-09 | 559 | 28 | 10 | GO:0042391 |
| GeneOntologyBiologicalProcess | muscle contraction | 1.77e-09 | 400 | 28 | 9 | GO:0006936 | |
| GeneOntologyBiologicalProcess | muscle system process | 2.68e-08 | 547 | 28 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 1.03e-07 | 173 | 28 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 1.10e-07 | 175 | 28 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.14e-07 | 648 | 28 | 9 | GO:0008015 | |
| GeneOntologyBiologicalProcess | circulatory system process | 3.24e-07 | 733 | 28 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 6.75e-07 | 238 | 28 | 6 | GO:0050954 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 8.38e-07 | 247 | 28 | 6 | GO:0009612 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus involved in sensory perception | 1.02e-06 | 57 | 28 | 4 | GO:0050974 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 2.01e-06 | 912 | 28 | 9 | GO:0030029 | |
| GeneOntologyBiologicalProcess | detection of stimulus | 3.62e-06 | 722 | 28 | 8 | GO:0051606 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 1.08e-05 | 32 | 28 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | behavior | 1.69e-05 | 891 | 28 | 8 | GO:0007610 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 2.43e-05 | 126 | 28 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception of pain | 2.67e-05 | 43 | 28 | 3 | GO:0062149 | |
| GeneOntologyBiologicalProcess | bundle of His cell action potential | 3.72e-05 | 7 | 28 | 2 | GO:0086043 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte signaling | 3.72e-05 | 7 | 28 | 2 | GO:0086028 | |
| GeneOntologyBiologicalProcess | response to pain | 4.47e-05 | 51 | 28 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | sensory perception | 6.34e-05 | 1072 | 28 | 8 | GO:0007600 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 7.94e-05 | 10 | 28 | 2 | GO:0060371 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 1.09e-04 | 582 | 28 | 6 | GO:0050906 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.16e-04 | 12 | 28 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.16e-04 | 12 | 28 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | bundle of His cell to Purkinje myocyte communication | 1.85e-04 | 15 | 28 | 2 | GO:0086069 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.85e-04 | 15 | 28 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 2.50e-04 | 230 | 28 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 3.32e-04 | 100 | 28 | 3 | GO:0061337 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 3.83e-04 | 105 | 28 | 3 | GO:0019233 | |
| GeneOntologyBiologicalProcess | nerve development | 4.27e-04 | 109 | 28 | 3 | GO:0021675 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 4.50e-04 | 111 | 28 | 3 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell membrane repolarization | 5.23e-04 | 25 | 28 | 2 | GO:0060307 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception of pain | 5.66e-04 | 26 | 28 | 2 | GO:0050965 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 6.11e-04 | 27 | 28 | 2 | GO:0098719 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 6.98e-04 | 129 | 28 | 3 | GO:0002027 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell membrane repolarization | 7.55e-04 | 30 | 28 | 2 | GO:0099625 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane repolarization | 7.55e-04 | 30 | 28 | 2 | GO:0099623 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus involved in sensory perception | 7.55e-04 | 30 | 28 | 2 | GO:0050961 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 8.06e-04 | 31 | 28 | 2 | GO:0007635 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 8.60e-04 | 32 | 28 | 2 | GO:0099505 | |
| GeneOntologyBiologicalProcess | detection of temperature stimulus | 9.14e-04 | 33 | 28 | 2 | GO:0016048 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 9.23e-04 | 142 | 28 | 3 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 9.23e-04 | 142 | 28 | 3 | GO:0099587 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 9.71e-04 | 34 | 28 | 2 | GO:0086019 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 1.15e-03 | 37 | 28 | 2 | GO:0086005 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.21e-03 | 38 | 28 | 2 | GO:0050951 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell membrane repolarization | 1.41e-03 | 41 | 28 | 2 | GO:0099622 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 1.41e-03 | 41 | 28 | 2 | GO:0086091 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization | 1.41e-03 | 41 | 28 | 2 | GO:0060306 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 1.86e-03 | 1361 | 28 | 7 | GO:0009628 | |
| GeneOntologyBiologicalProcess | adult walking behavior | 2.09e-03 | 50 | 28 | 2 | GO:0007628 | |
| GeneOntologyBiologicalProcess | determination of adult lifespan | 2.43e-03 | 54 | 28 | 2 | GO:0008340 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 2.53e-03 | 202 | 28 | 3 | GO:0006937 | |
| GeneOntologyBiologicalProcess | membrane repolarization | 2.62e-03 | 56 | 28 | 2 | GO:0086009 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.90e-03 | 59 | 28 | 2 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of proteasomal protein catabolic process | 2.94e-03 | 213 | 28 | 3 | GO:0061136 | |
| GeneOntologyBiologicalProcess | walking behavior | 3.00e-03 | 60 | 28 | 2 | GO:0090659 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 3.10e-03 | 61 | 28 | 2 | GO:0003254 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 4.56e-03 | 249 | 28 | 3 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of proteolysis involved in protein catabolic process | 4.87e-03 | 255 | 28 | 3 | GO:1903050 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 5.39e-03 | 81 | 28 | 2 | GO:0098900 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 5.82e-03 | 272 | 28 | 3 | GO:0006813 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 6.47e-03 | 89 | 28 | 2 | GO:0055117 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 8.30e-20 | 17 | 28 | 8 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.45e-17 | 29 | 28 | 8 | GO:0034706 | |
| GeneOntologyCellularComponent | cation channel complex | 1.41e-11 | 235 | 28 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 9.59e-10 | 378 | 28 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.62e-08 | 523 | 28 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 2.50e-08 | 550 | 28 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 5.15e-07 | 785 | 28 | 9 | GO:0098797 | |
| GeneOntologyCellularComponent | node of Ranvier | 2.42e-06 | 20 | 28 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | axon initial segment | 7.68e-06 | 29 | 28 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | axon | 1.53e-05 | 891 | 28 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.02e-05 | 277 | 28 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | membrane protein complex | 9.63e-05 | 1498 | 28 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | intercalated disc | 1.02e-04 | 68 | 28 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.02e-04 | 583 | 28 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | T-tubule | 1.59e-04 | 79 | 28 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | main axon | 2.26e-04 | 89 | 28 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.66e-04 | 94 | 28 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | presynapse | 9.64e-04 | 886 | 28 | 6 | GO:0098793 | |
| GeneOntologyCellularComponent | Z disc | 1.06e-03 | 151 | 28 | 3 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 1.39e-03 | 166 | 28 | 3 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcolemma | 2.05e-03 | 190 | 28 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.19e-03 | 817 | 28 | 5 | GO:0098978 | |
| GeneOntologyCellularComponent | sarcomere | 4.39e-03 | 249 | 28 | 3 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 5.67e-03 | 273 | 28 | 3 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.70e-03 | 290 | 28 | 3 | GO:0043292 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 3.43e-08 | 15 | 13 | 4 | HP:0007207 | |
| HumanPheno | Complex febrile seizure | 4.57e-08 | 16 | 13 | 4 | HP:0011172 | |
| HumanPheno | Visually-induced seizure | 7.65e-08 | 18 | 13 | 4 | HP:0020216 | |
| HumanPheno | Reflex seizure | 1.82e-07 | 22 | 13 | 4 | HP:0020207 | |
| HumanPheno | Focal hemiclonic seizure | 3.13e-07 | 25 | 13 | 4 | HP:0006813 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 3.65e-07 | 130 | 13 | 6 | HP:0012332 | |
| HumanPheno | Simple febrile seizure | 4.33e-07 | 27 | 13 | 4 | HP:0011171 | |
| HumanPheno | Infection-related seizure | 6.99e-07 | 145 | 13 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 6.99e-07 | 145 | 13 | 6 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 6.99e-07 | 145 | 13 | 6 | HP:0002373 | |
| HumanPheno | Photosensitive myoclonic seizure | 7.22e-07 | 8 | 13 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 7.22e-07 | 8 | 13 | 3 | HP:0200048 | |
| HumanPheno | Clonic seizure | 1.05e-06 | 81 | 13 | 5 | HP:0020221 | |
| HumanPheno | Generalized clonic seizure | 1.13e-06 | 34 | 13 | 4 | HP:0011169 | |
| HumanPheno | EEG with spike-wave complexes | 1.58e-06 | 88 | 13 | 5 | HP:0010850 | |
| HumanPheno | Limited neck range of motion | 2.12e-06 | 11 | 13 | 3 | HP:0000466 | |
| HumanPheno | Focal clonic seizure | 2.71e-06 | 42 | 13 | 4 | HP:0002266 | |
| HumanPheno | Bradycardia | 2.71e-06 | 98 | 13 | 5 | HP:0001662 | |
| HumanPheno | Epilepsia partialis continua | 2.82e-06 | 12 | 13 | 3 | HP:0012847 | |
| HumanPheno | Focal automatism seizure | 2.82e-06 | 12 | 13 | 3 | HP:0032898 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 3.66e-06 | 13 | 13 | 3 | HP:0007058 | |
| HumanPheno | Status epilepticus | 5.66e-06 | 207 | 13 | 6 | HP:0002133 | |
| HumanPheno | Facial tics | 5.81e-06 | 15 | 13 | 3 | HP:0011468 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 6.45e-06 | 52 | 13 | 4 | HP:0025190 | |
| HumanPheno | Cyanosis | 6.52e-06 | 117 | 13 | 5 | HP:0000961 | |
| HumanPheno | Dysgenesis of the hippocampus | 7.14e-06 | 16 | 13 | 3 | HP:0025101 | |
| HumanPheno | Focal motor status epilepticus | 8.65e-06 | 17 | 13 | 3 | HP:0032663 | |
| HumanPheno | Atypical absence status epilepticus | 8.65e-06 | 17 | 13 | 3 | HP:0011151 | |
| HumanPheno | Pes valgus | 8.70e-06 | 56 | 13 | 4 | HP:0008081 | |
| HumanPheno | Focal impaired awareness seizure | 9.39e-06 | 126 | 13 | 5 | HP:0002384 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 1.04e-05 | 18 | 13 | 3 | HP:0032860 | |
| HumanPheno | Sudden death | 1.14e-05 | 131 | 13 | 5 | HP:0001699 | |
| HumanPheno | Abnormal cardiac exercise stress test | 1.23e-05 | 19 | 13 | 3 | HP:0500018 | |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.44e-05 | 20 | 13 | 3 | HP:0032671 | |
| HumanPheno | Generalized tonic seizure | 1.49e-05 | 64 | 13 | 4 | HP:0010818 | |
| HumanPheno | Talipes valgus | 1.68e-05 | 21 | 13 | 3 | HP:0004684 | |
| HumanPheno | Multifocal epileptiform discharges | 1.68e-05 | 66 | 13 | 4 | HP:0010841 | |
| HumanPheno | Dialeptic seizure | 1.73e-05 | 251 | 13 | 6 | HP:0011146 | |
| HumanPheno | Poor fine motor coordination | 2.01e-05 | 69 | 13 | 4 | HP:0007010 | |
| HumanPheno | Generalized myoclonic seizure | 2.06e-05 | 148 | 13 | 5 | HP:0002123 | |
| HumanPheno | Impulsivity | 2.13e-05 | 149 | 13 | 5 | HP:0100710 | |
| HumanPheno | Tibial torsion | 2.23e-05 | 23 | 13 | 3 | HP:0100694 | |
| HumanPheno | EEG with generalized epileptiform discharges | 2.63e-05 | 270 | 13 | 6 | HP:0011198 | |
| HumanPheno | Torsade de pointes | 2.89e-05 | 25 | 13 | 3 | HP:0001664 | |
| HumanPheno | Hypokalemia | 3.45e-05 | 79 | 13 | 4 | HP:0002900 | |
| HumanPheno | Limited knee extension | 3.67e-05 | 27 | 13 | 3 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 3.67e-05 | 27 | 13 | 3 | HP:0031475 | |
| HumanPheno | Focal aware seizure | 4.10e-05 | 28 | 13 | 3 | HP:0002349 | |
| HumanPheno | Status epilepticus with prominent motor symptoms | 4.57e-05 | 29 | 13 | 3 | HP:0032658 | |
| HumanPheno | Prolonged QTc interval | 4.57e-05 | 29 | 13 | 3 | HP:0005184 | |
| HumanPheno | Poor motor coordination | 4.60e-05 | 85 | 13 | 4 | HP:0002275 | |
| HumanPheno | Generalized non-motor (absence) seizure | 4.78e-05 | 176 | 13 | 5 | HP:0002121 | |
| HumanPheno | Progressive gait ataxia | 5.07e-05 | 30 | 13 | 3 | HP:0007240 | |
| HumanPheno | Sinus bradycardia | 5.07e-05 | 30 | 13 | 3 | HP:0001688 | |
| HumanPheno | Progressive ataxia | 5.07e-05 | 30 | 13 | 3 | HP:0001329 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 5.99e-05 | 5 | 13 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 5.99e-05 | 5 | 13 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 5.99e-05 | 5 | 13 | 2 | HP:0032906 | |
| HumanPheno | Allodynia | 5.99e-05 | 5 | 13 | 2 | HP:0012533 | |
| HumanPheno | Cogwheel rigidity | 6.17e-05 | 32 | 13 | 3 | HP:0002396 | |
| HumanPheno | Obsessive-compulsive trait | 6.78e-05 | 33 | 13 | 3 | HP:0008770 | |
| HumanPheno | Interictal epileptiform activity | 6.78e-05 | 319 | 13 | 6 | HP:0011182 | |
| HumanPheno | Abnormal nervous system electrophysiology | 7.28e-05 | 924 | 13 | 9 | HP:0001311 | |
| HumanPheno | Calcaneovalgus deformity | 7.43e-05 | 34 | 13 | 3 | HP:0001848 | |
| HumanPheno | Interictal EEG abnormality | 7.54e-05 | 325 | 13 | 6 | HP:0025373 | |
| HumanPheno | Deformed tarsal bones | 8.11e-05 | 35 | 13 | 3 | HP:0008119 | |
| HumanPheno | Limitation of knee mobility | 8.11e-05 | 35 | 13 | 3 | HP:0010501 | |
| HumanPheno | Non-motor seizure | 8.21e-05 | 197 | 13 | 5 | HP:0033259 | |
| HumanPheno | Limitation of neck motion | 8.83e-05 | 36 | 13 | 3 | HP:0005986 | |
| HumanPheno | Abnormal neck physiology | 8.83e-05 | 36 | 13 | 3 | HP:0025669 | |
| HumanPheno | Disturbance of facial expression | 8.83e-05 | 36 | 13 | 3 | HP:0005324 | |
| HumanPheno | Normal interictal EEG | 8.97e-05 | 6 | 13 | 2 | HP:0002372 | |
| HumanPheno | Abnormal T-wave | 9.60e-05 | 37 | 13 | 3 | HP:0005135 | |
| HumanPheno | Abnormality of the autonomic nervous system | 1.07e-04 | 346 | 13 | 6 | HP:0002270 | |
| HumanPheno | Abnormal tibia morphology | 1.14e-04 | 107 | 13 | 4 | HP:0002992 | |
| HumanPheno | Focal non-motor seizure | 1.22e-04 | 40 | 13 | 3 | HP:0032679 | |
| HumanPheno | Rigidity | 1.22e-04 | 214 | 13 | 5 | HP:0002063 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | 1.22e-04 | 738 | 13 | 8 | HP:0030178 | |
| HumanPheno | Eyelid myoclonia seizure | 1.25e-04 | 7 | 13 | 2 | HP:0032678 | |
| HumanPheno | Abnormal blood potassium concentration | 1.41e-04 | 113 | 13 | 4 | HP:0011042 | |
| HumanPheno | EEG abnormality | 1.54e-04 | 548 | 13 | 7 | HP:0002353 | |
| HumanPheno | Myoclonus | 1.58e-04 | 371 | 13 | 6 | HP:0001336 | |
| HumanPheno | Generalized-onset motor seizure | 1.65e-04 | 228 | 13 | 5 | HP:0032677 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.66e-04 | 118 | 13 | 4 | HP:0011185 | |
| HumanPheno | Premature atrial contractions | 1.67e-04 | 8 | 13 | 2 | HP:0006699 | |
| HumanPheno | Epileptic encephalopathy | 1.72e-04 | 119 | 13 | 4 | HP:0200134 | |
| HumanPheno | Reduced impulse control | 1.80e-04 | 1032 | 13 | 9 | HP:5200045 | |
| HumanPheno | Atypical absence seizure | 1.85e-04 | 46 | 13 | 3 | HP:0007270 | |
| HumanPheno | Abnormal hippocampus morphology | 2.10e-04 | 48 | 13 | 3 | HP:0025100 | |
| HumanPheno | Permanent atrial fibrillation | 2.14e-04 | 9 | 13 | 2 | HP:0004754 | |
| HumanPheno | Bilateral tonic-clonic seizure | 2.21e-04 | 394 | 13 | 6 | HP:0002069 | |
| HumanPheno | Abnormal morphology of the limbic system | 2.24e-04 | 49 | 13 | 3 | HP:0007343 | |
| HumanPheno | Focal motor seizure | 2.49e-04 | 131 | 13 | 4 | HP:0011153 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 2.67e-04 | 52 | 13 | 3 | HP:0007334 | |
| HumanPheno | Apneic episodes in infancy | 2.67e-04 | 10 | 13 | 2 | HP:0005949 | |
| HumanPheno | Sudden unexpected death in epilepsy | 2.67e-04 | 10 | 13 | 2 | HP:0033258 | |
| HumanPheno | Erythromelalgia | 2.67e-04 | 10 | 13 | 2 | HP:0032147 | |
| HumanPheno | Prolonged QT interval | 2.99e-04 | 54 | 13 | 3 | HP:0001657 | |
| MousePheno | abnormal action potential | 3.20e-08 | 133 | 21 | 6 | MP:0005402 | |
| MousePheno | abnormal nervous system electrophysiology | 6.54e-06 | 329 | 21 | 6 | MP:0002272 | |
| MousePheno | ventricular fibrillation | 4.49e-05 | 7 | 21 | 2 | MP:0006110 | |
| MousePheno | abnormal stationary movement | 6.11e-05 | 147 | 21 | 4 | MP:0001388 | |
| MousePheno | abnormal breathing pattern | 7.08e-05 | 303 | 21 | 5 | MP:0001951 | |
| MousePheno | increased locomotor activity | 1.28e-04 | 178 | 21 | 4 | MP:0031391 | |
| MousePheno | impaired ability to fire action potentials | 1.66e-04 | 13 | 21 | 2 | MP:0002578 | |
| MousePheno | abnormal respiration | 1.87e-04 | 598 | 21 | 6 | MP:0001943 | |
| MousePheno | fibrillation | 1.93e-04 | 14 | 21 | 2 | MP:0006109 | |
| MousePheno | sinus bradycardia | 1.93e-04 | 14 | 21 | 2 | MP:0010637 | |
| MousePheno | abnormal respiratory function | 2.58e-04 | 399 | 21 | 5 | MP:0002327 | |
| MousePheno | akinesia | 4.44e-04 | 21 | 21 | 2 | MP:0002690 | |
| MousePheno | abnormal head movements | 4.69e-04 | 103 | 21 | 3 | MP:0000436 | |
| MousePheno | increased vertical activity | 4.70e-04 | 250 | 21 | 4 | MP:0002574 | |
| MousePheno | abnormal spatial reference memory | 5.25e-04 | 107 | 21 | 3 | MP:0008414 | |
| MousePheno | abnormal spike wave discharge | 5.82e-04 | 24 | 21 | 2 | MP:0008840 | |
| MousePheno | ventricular premature beat | 6.32e-04 | 25 | 21 | 2 | MP:0009732 | |
| MousePheno | apnea | 7.38e-04 | 27 | 21 | 2 | MP:0001957 | |
| MousePheno | impaired muscle relaxation | 7.94e-04 | 28 | 21 | 2 | MP:0003157 | |
| MousePheno | abnormal seizure response to electrical stimulation | 1.04e-03 | 32 | 21 | 2 | MP:0001650 | |
| MousePheno | hyperactivity | 1.16e-03 | 1172 | 21 | 7 | MP:0001399 | |
| MousePheno | abnormal single cell response | 1.24e-03 | 35 | 21 | 2 | MP:0003463 | |
| MousePheno | absence seizures | 1.24e-03 | 35 | 21 | 2 | MP:0003216 | |
| MousePheno | abnormal mechanical nociception | 1.31e-03 | 36 | 21 | 2 | MP:0002734 | |
| MousePheno | abnormal respiratory system physiology | 1.62e-03 | 897 | 21 | 6 | MP:0002133 | |
| MousePheno | nonconvulsive seizures | 1.62e-03 | 40 | 21 | 2 | MP:0000948 | |
| MousePheno | abnormal spermatogonia morphology | 1.78e-03 | 42 | 21 | 2 | MP:0006378 | |
| MousePheno | seizures | 1.83e-03 | 360 | 21 | 4 | MP:0002064 | |
| MousePheno | abnormal social investigation | 2.03e-03 | 171 | 21 | 3 | MP:0001360 | |
| Domain | Na_channel_asu | 2.72e-22 | 10 | 27 | 8 | IPR001696 | |
| Domain | Na_trans_assoc | 2.72e-22 | 10 | 27 | 8 | IPR010526 | |
| Domain | Na_trans_assoc | 2.72e-22 | 10 | 27 | 8 | PF06512 | |
| Domain | Na_trans_cytopl | 5.03e-18 | 6 | 27 | 6 | PF11933 | |
| Domain | Na_trans_cytopl | 5.03e-18 | 6 | 27 | 6 | IPR024583 | |
| Domain | Channel_four-helix_dom | 5.32e-17 | 57 | 27 | 9 | IPR027359 | |
| Domain | - | 5.32e-17 | 57 | 27 | 9 | 1.20.120.350 | |
| Domain | IQ_motif_EF-hand-BS | 4.36e-13 | 90 | 27 | 8 | IPR000048 | |
| Domain | IQ | 5.71e-13 | 93 | 27 | 8 | PS50096 | |
| Domain | Ion_trans_dom | 3.03e-12 | 114 | 27 | 8 | IPR005821 | |
| Domain | Ion_trans | 3.03e-12 | 114 | 27 | 8 | PF00520 | |
| Domain | IQ | 1.83e-11 | 81 | 27 | 7 | SM00015 | |
| Domain | IQ | 6.76e-10 | 71 | 27 | 6 | PF00612 | |
| Domain | REJ_dom | 1.21e-05 | 4 | 27 | 2 | IPR014010 | |
| Domain | REJ | 1.21e-05 | 4 | 27 | 2 | PS51111 | |
| Domain | PKD_2 | 2.01e-05 | 5 | 27 | 2 | IPR003915 | |
| Domain | REJ | 3.01e-05 | 6 | 27 | 2 | PF02010 | |
| Domain | PKD/REJ-like | 3.01e-05 | 6 | 27 | 2 | IPR002859 | |
| Domain | PKD1_2_channel | 1.10e-04 | 11 | 27 | 2 | IPR013122 | |
| Domain | PKD_channel | 1.10e-04 | 11 | 27 | 2 | PF08016 | |
| Domain | ABC_A | 1.32e-04 | 12 | 27 | 2 | IPR026082 | |
| Domain | LH2 | 3.04e-04 | 18 | 27 | 2 | SM00308 | |
| Domain | PLAT | 4.16e-04 | 21 | 27 | 2 | PS50095 | |
| Domain | PLAT/LH2_dom | 4.16e-04 | 21 | 27 | 2 | IPR001024 | |
| Domain | - | 4.16e-04 | 21 | 27 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.16e-04 | 21 | 27 | 2 | PF01477 | |
| Domain | EF-hand-dom_pair | 7.25e-04 | 287 | 27 | 4 | IPR011992 | |
| Domain | GPS | 1.10e-03 | 34 | 27 | 2 | SM00303 | |
| Domain | GPS | 1.30e-03 | 37 | 27 | 2 | IPR000203 | |
| Domain | ABC_TRANSPORTER_2 | 2.18e-03 | 48 | 27 | 2 | PS50893 | |
| Domain | ABC_tran | 2.18e-03 | 48 | 27 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 2.27e-03 | 49 | 27 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 2.36e-03 | 50 | 27 | 2 | IPR003439 | |
| Domain | AAA+_ATPase | 1.83e-02 | 144 | 27 | 2 | IPR003593 | |
| Domain | AAA | 1.83e-02 | 144 | 27 | 2 | SM00382 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.53e-17 | 31 | 20 | 8 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 3.37e-17 | 32 | 20 | 8 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.90e-14 | 121 | 20 | 9 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.62e-14 | 130 | 20 | 9 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 3.27e-12 | 203 | 20 | 9 | M5485 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 1.87e-08 | 367 | 20 | 8 | M48346 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.30e-08 | 575 | 20 | 9 | M29853 | |
| Pathway | WP_DRAVET_SYNDROME | 5.90e-08 | 28 | 20 | 4 | M45519 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 3.57e-05 | 46 | 20 | 3 | M46450 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 3.81e-05 | 47 | 20 | 3 | M42524 | |
| Pathway | WP_RETT_SYNDROME | 4.06e-05 | 48 | 20 | 3 | M39759 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.66e-05 | 1432 | 20 | 9 | M509 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.62e-03 | 636 | 20 | 5 | M41834 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.75e-03 | 44 | 20 | 2 | M11911 | |
| Pubmed | 5.27e-25 | 9 | 28 | 8 | 16382098 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.53e-19 | 6 | 28 | 6 | 23652591 | |
| Pubmed | 1.66e-19 | 13 | 28 | 7 | 15123669 | ||
| Pubmed | 1.29e-17 | 9 | 28 | 6 | 15746173 | ||
| Pubmed | 2.32e-16 | 5 | 28 | 5 | 17724025 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.54e-13 | 139 | 28 | 8 | 16985003 | |
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.83e-13 | 12 | 28 | 5 | 30175250 | |
| Pubmed | 3.36e-13 | 4 | 28 | 4 | 17537961 | ||
| Pubmed | 3.36e-13 | 4 | 28 | 4 | 35031483 | ||
| Pubmed | 3.36e-13 | 4 | 28 | 4 | 29578003 | ||
| Pubmed | 1.68e-12 | 5 | 28 | 4 | 8812438 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 1.68e-12 | 5 | 28 | 4 | 22875929 | |
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 19284629 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 12610651 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 33895391 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 17928448 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 23859570 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 19699781 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 14973256 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 18784617 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 17544618 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 32845893 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 20038812 | ||
| Pubmed | 4.67e-10 | 3 | 28 | 3 | 28518218 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 21156207 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 35801810 | ||
| Pubmed | 1.87e-09 | 4 | 28 | 3 | 22260870 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.87e-09 | 4 | 28 | 3 | 8974318 | |
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 1679748 | ||
| Pubmed | 4.67e-09 | 5 | 28 | 3 | 24337656 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 16029194 | ||
| Pubmed | 9.33e-09 | 6 | 28 | 3 | 23711479 | ||
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 15272007 | ||
| Pubmed | Pain without nociceptors? Nav1.7-independent pain mechanisms. | 1.63e-08 | 7 | 28 | 3 | 24440715 | |
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 1.63e-08 | 7 | 28 | 3 | 25818041 | |
| Pubmed | 1.63e-08 | 7 | 28 | 3 | 23575686 | ||
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 25101983 | ||
| Pubmed | 2.61e-08 | 8 | 28 | 3 | 9412493 | ||
| Pubmed | Genetic mapping of the peripheral sodium channel genes, Scn9a and Scn10a, in the mouse. | 3.91e-08 | 9 | 28 | 3 | 8854872 | |
| Pubmed | Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. | 3.91e-08 | 9 | 28 | 3 | 17884088 | |
| Pubmed | 1.02e-07 | 12 | 28 | 3 | 8169823 | ||
| Pubmed | A high-density association screen of 155 ion transport genes for involvement with common migraine. | 1.02e-07 | 12 | 28 | 3 | 18676988 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 2.11e-07 | 15 | 28 | 3 | 9726281 | |
| Pubmed | A common genetic variant within SCN10A modulates cardiac SCN5A expression. | 6.25e-07 | 2 | 28 | 2 | 24642470 | |
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 6.25e-07 | 2 | 28 | 2 | 16054936 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 29649454 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 6.25e-07 | 2 | 28 | 2 | 17805013 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 20346423 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33712547 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26311622 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 6.25e-07 | 2 | 28 | 2 | 37901435 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33411788 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18079277 | ||
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 6.25e-07 | 2 | 28 | 2 | 26410685 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31943325 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 11834499 | ||
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 6.25e-07 | 2 | 28 | 2 | 10827969 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 6.25e-07 | 2 | 28 | 2 | 15249644 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 27690330 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 19694741 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 6.25e-07 | 2 | 28 | 2 | 11245985 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26861708 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15047701 | ||
| Pubmed | Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. | 6.25e-07 | 2 | 28 | 2 | 16111501 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15760941 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 6.25e-07 | 2 | 28 | 2 | 27174182 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21377452 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 6.25e-07 | 2 | 28 | 2 | 1317301 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18601978 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 6.25e-07 | 2 | 28 | 2 | 24998131 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 6.25e-07 | 2 | 28 | 2 | 23965409 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 6.25e-07 | 2 | 28 | 2 | 23016767 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 27153334 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 33096315 | ||
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 6.25e-07 | 2 | 28 | 2 | 19465131 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 6.25e-07 | 2 | 28 | 2 | 24990319 | |
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 6.25e-07 | 2 | 28 | 2 | 30944319 | |
| Pubmed | Na+ current properties in islet α- and β-cells reflect cell-specific Scn3a and Scn9a expression. | 6.25e-07 | 2 | 28 | 2 | 25172946 | |
| Pubmed | Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. | 6.25e-07 | 2 | 28 | 2 | 16847056 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31439038 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 24360055 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31292628 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 6.25e-07 | 2 | 28 | 2 | 37665666 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 17881658 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 6.25e-07 | 2 | 28 | 2 | 23735284 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 32330377 | ||
| Pubmed | 9.35e-07 | 24 | 28 | 3 | 20301690 | ||
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 1.87e-06 | 3 | 28 | 2 | 24704313 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19270815 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 28784306 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 16052353 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32185219 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 38999942 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15314237 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32005694 | ||
| Pubmed | The cell and molecular basis of mechanical, cold, and inflammatory pain. | 1.87e-06 | 3 | 28 | 2 | 18669863 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 15316014 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 25155934 | ||
| Interaction | SCN11A interactions | 5.71e-12 | 15 | 25 | 5 | int:SCN11A | |
| Interaction | SCN5A interactions | 2.84e-09 | 47 | 25 | 5 | int:SCN5A | |
| Interaction | CACNA1D interactions | 1.92e-08 | 24 | 25 | 4 | int:CACNA1D | |
| Interaction | SCN1A interactions | 4.28e-08 | 29 | 25 | 4 | int:SCN1A | |
| Interaction | NEDD4L interactions | 8.96e-08 | 320 | 25 | 7 | int:NEDD4L | |
| Interaction | SCN4B interactions | 9.40e-08 | 8 | 25 | 3 | int:SCN4B | |
| Interaction | SCN10A interactions | 2.76e-07 | 11 | 25 | 3 | int:SCN10A | |
| Interaction | NALCN interactions | 6.08e-07 | 14 | 25 | 3 | int:NALCN | |
| Interaction | CACNA1C interactions | 9.16e-07 | 61 | 25 | 4 | int:CACNA1C | |
| Interaction | SCN8A interactions | 1.90e-06 | 20 | 25 | 3 | int:SCN8A | |
| Interaction | SCN9A interactions | 2.21e-06 | 21 | 25 | 3 | int:SCN9A | |
| Interaction | NEDD4 interactions | 3.16e-06 | 544 | 25 | 7 | int:NEDD4 | |
| Interaction | CACNA1B interactions | 1.27e-05 | 37 | 25 | 3 | int:CACNA1B | |
| Interaction | CACNA1A interactions | 1.51e-05 | 123 | 25 | 4 | int:CACNA1A | |
| Interaction | ABCA8 interactions | 5.29e-05 | 9 | 25 | 2 | int:ABCA8 | |
| Interaction | ABCA6 interactions | 6.61e-05 | 10 | 25 | 2 | int:ABCA6 | |
| Interaction | CALM1 interactions | 9.38e-05 | 626 | 25 | 6 | int:CALM1 | |
| Interaction | SCN4A interactions | 2.37e-04 | 98 | 25 | 3 | int:SCN4A | |
| Interaction | SNTA1 interactions | 2.91e-04 | 105 | 25 | 3 | int:SNTA1 | |
| Interaction | PIGW interactions | 4.71e-04 | 26 | 25 | 2 | int:PIGW | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.09e-06 | 127 | 28 | 4 | chr2q24 | |
| Cytoband | 2q24 | 1.97e-05 | 11 | 28 | 2 | 2q24 | |
| Cytoband | 2q24.3 | 4.28e-05 | 16 | 28 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q24 | 1.64e-03 | 98 | 28 | 2 | chr17q24 | |
| Cytoband | 1q44 | 2.06e-03 | 110 | 28 | 2 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 2.78e-03 | 128 | 28 | 2 | chr1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p22 | 5.64e-03 | 184 | 28 | 2 | chr3p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q13 | 8.03e-03 | 221 | 28 | 2 | chr3q13 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.40e-24 | 9 | 19 | 8 | 1203 | |
| GeneFamily | ATP binding cassette subfamily A | 9.45e-05 | 14 | 19 | 2 | 805 | |
| GeneFamily | Olfactory receptors, family 2 | 6.18e-03 | 113 | 19 | 2 | 149 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.60e-06 | 155 | 28 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.74e-06 | 157 | 28 | 4 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-06 | 158 | 28 | 4 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-06 | 178 | 28 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 4.60e-06 | 179 | 28 | 4 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-06 | 181 | 28 | 4 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.92e-06 | 182 | 28 | 4 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-06 | 183 | 28 | 4 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-06 | 184 | 28 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-06 | 184 | 28 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.13e-06 | 184 | 28 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 186 | 28 | 4 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.36e-06 | 186 | 28 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.36e-06 | 186 | 28 | 4 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.59e-06 | 188 | 28 | 4 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.71e-06 | 189 | 28 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Neuroendocrine-neuroendo-2-Calca|World / Class top | 5.71e-06 | 189 | 28 | 4 | 6baa9a74560121cc008bb8fa9b2b7a335b3aeee0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 190 | 28 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.83e-06 | 190 | 28 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-06 | 191 | 28 | 4 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 192 | 28 | 4 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 192 | 28 | 4 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-06 | 192 | 28 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 192 | 28 | 4 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.07e-06 | 192 | 28 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | Neuroendocrine|World / Class top | 6.07e-06 | 192 | 28 | 4 | 0199da3ef9ddb6673e9aa41f346f374838aec182 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.07e-06 | 192 | 28 | 4 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.07e-06 | 192 | 28 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 193 | 28 | 4 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.20e-06 | 193 | 28 | 4 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 193 | 28 | 4 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 193 | 28 | 4 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 193 | 28 | 4 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 193 | 28 | 4 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 193 | 28 | 4 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-06 | 193 | 28 | 4 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.33e-06 | 194 | 28 | 4 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | distal-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.46e-06 | 195 | 28 | 4 | 8e0f67a67af3bc0b16f48a621f74540f136383b7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.46e-06 | 195 | 28 | 4 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.46e-06 | 195 | 28 | 4 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.46e-06 | 195 | 28 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | distal-Endothelial-Lymphatic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.46e-06 | 195 | 28 | 4 | f45c1349932ee7eb419cced8a4fdedae3610953f | |
| ToppCell | distal-Endothelial-Lymphatic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.59e-06 | 196 | 28 | 4 | 3e8a20e1d163dcbd3bbd99fe179d54af02298af0 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.59e-06 | 196 | 28 | 4 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 197 | 28 | 4 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.72e-06 | 197 | 28 | 4 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-06 | 198 | 28 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | medial-Endothelial-Lymphatic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.86e-06 | 198 | 28 | 4 | 41983d405215b974044e2e9e6c212b134336a6fe | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-06 | 198 | 28 | 4 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | medial-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.86e-06 | 198 | 28 | 4 | e4274584512a72270087a1ab104fab449a2f83bc | |
| ToppCell | medial-Endothelial-Lymphatic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.86e-06 | 198 | 28 | 4 | 1760fede363544bc0fa2e22fe36aff522abd2525 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-06 | 198 | 28 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 7.00e-06 | 199 | 28 | 4 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.00e-06 | 199 | 28 | 4 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.00e-06 | 199 | 28 | 4 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.14e-06 | 200 | 28 | 4 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.14e-06 | 200 | 28 | 4 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | RV-14._Fibroblast_III|RV / Chamber and Cluster_Paper | 9.12e-05 | 140 | 28 | 3 | b4fee8eb6bf855b364b00bda3f78e49d851bbca0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.32e-05 | 141 | 28 | 3 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 145 | 28 | 3 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 145 | 28 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 150 | 28 | 3 | 47ea08d7609e1d2382bf56ef9e5c767e3597cf93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 150 | 28 | 3 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 150 | 28 | 3 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 158 | 28 | 3 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 158 | 28 | 3 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.33e-04 | 159 | 28 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 161 | 28 | 3 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 161 | 28 | 3 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 161 | 28 | 3 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 161 | 28 | 3 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.41e-04 | 162 | 28 | 3 | 7f9385aa749bfb2fa9fee6939fe46d946bc21d31 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-04 | 162 | 28 | 3 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 163 | 28 | 3 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 163 | 28 | 3 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-04 | 164 | 28 | 3 | 57301178e420983c0cb72178e288a3a0449fdda3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.46e-04 | 164 | 28 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 165 | 28 | 3 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.48e-04 | 165 | 28 | 3 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 165 | 28 | 3 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.48e-04 | 165 | 28 | 3 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 165 | 28 | 3 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-04 | 165 | 28 | 3 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.51e-04 | 166 | 28 | 3 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 166 | 28 | 3 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.56e-04 | 168 | 28 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | Endothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-04 | 169 | 28 | 3 | 8889c9e8af1ab0b093d57b69abd80b59b3461be9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 169 | 28 | 3 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 169 | 28 | 3 | 0332f539a2f7d6dcd081a5d2f567290721f5a329 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.59e-04 | 169 | 28 | 3 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | ICU-SEP-Myeloid-pDC|ICU-SEP / Disease, Lineage and Cell Type | 1.65e-04 | 171 | 28 | 3 | 72c448a0dc4c569bd6b465f9aa395f38034e7ea6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 171 | 28 | 3 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 171 | 28 | 3 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.65e-04 | 171 | 28 | 3 | 9d5cabd71a901a00eb16c4d151189296f1b3bf6f | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.68e-04 | 172 | 28 | 3 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| Drug | APETx1, Anthopleura elegantissima | 1.16e-14 | 6 | 28 | 5 | ctd:C475726 | |
| Drug | Zonisamide | 2.39e-14 | 17 | 28 | 6 | DB00909 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 1.28e-10 | 8 | 28 | 4 | ctd:C489827 | |
| Drug | AC1L1MOZ | 1.53e-10 | 27 | 28 | 5 | CID000031958 | |
| Drug | mexiletine | 1.68e-10 | 66 | 28 | 6 | CID000004178 | |
| Drug | dibucaine | 2.03e-10 | 68 | 28 | 6 | CID000003025 | |
| Drug | flecainide | 2.64e-10 | 71 | 28 | 6 | CID000003355 | |
| Drug | tocainide | 2.69e-10 | 30 | 28 | 5 | CID000038945 | |
| Drug | Sodium | 7.42e-10 | 84 | 28 | 6 | ctd:D012964 | |
| Drug | benzocaine | 8.18e-10 | 37 | 28 | 5 | CID000002337 | |
| Drug | Tetrodotoxin | 1.23e-09 | 40 | 28 | 5 | ctd:D013779 | |
| Drug | N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide | 1.67e-09 | 3 | 28 | 3 | ctd:C561228 | |
| Drug | pilsicainide | 2.55e-09 | 46 | 28 | 5 | CID000004820 | |
| Drug | verapamil | 4.42e-09 | 490 | 28 | 9 | CID000002520 | |
| Drug | lamotrigine | 5.28e-09 | 116 | 28 | 6 | CID000003878 | |
| Drug | Scorpion Venoms | 5.53e-09 | 18 | 28 | 4 | ctd:D012604 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 6.66e-09 | 4 | 28 | 3 | ctd:C501880 | |
| Drug | Lidocaine | 6.66e-09 | 4 | 28 | 3 | DB00281 | |
| Drug | diprafenone | 7.00e-09 | 19 | 28 | 4 | CID000071249 | |
| Drug | triamterene | 8.45e-09 | 58 | 28 | 5 | CID000005546 | |
| Drug | saxitoxin | 1.51e-08 | 65 | 28 | 5 | CID000037165 | |
| Drug | AC1L1CQC | 1.51e-08 | 65 | 28 | 5 | CID000002012 | |
| Drug | disopyramide | 1.64e-08 | 66 | 28 | 5 | CID000003114 | |
| Drug | AC1NT1AF | 2.27e-08 | 25 | 28 | 4 | CID005322157 | |
| Drug | Pirmenolum | 2.68e-08 | 26 | 28 | 4 | CID000004853 | |
| Drug | 1, 3-diallylurea | 2.93e-08 | 74 | 28 | 5 | CID000074537 | |
| Drug | nefopam | 3.15e-08 | 27 | 28 | 4 | CID000004450 | |
| Drug | PbTx-1 | 3.15e-08 | 27 | 28 | 4 | CID006437089 | |
| Drug | fenpropathrin | 3.32e-08 | 6 | 28 | 3 | ctd:C044267 | |
| Drug | lidocaine | 3.63e-08 | 160 | 28 | 6 | CID000003676 | |
| Drug | paraben | 3.67e-08 | 28 | 28 | 4 | CID000007175 | |
| Drug | NSC93767 | 6.42e-08 | 32 | 28 | 4 | CID000005658 | |
| Drug | carbamazepine | 7.09e-08 | 179 | 28 | 6 | CID000002554 | |
| Drug | NSC7524 | 7.82e-08 | 182 | 28 | 6 | CID000005657 | |
| Drug | 5-hydroxypropafenone | 8.27e-08 | 34 | 28 | 4 | CID000107927 | |
| Drug | propafenone | 1.21e-07 | 98 | 28 | 5 | CID000004932 | |
| Drug | aprindine | 1.31e-07 | 38 | 28 | 4 | CID000002218 | |
| Drug | Mexiletine | 1.39e-07 | 9 | 28 | 3 | ctd:D008801 | |
| Drug | AC1NPPZW | 1.55e-07 | 103 | 28 | 5 | CID005183170 | |
| Drug | S-ropivacaine | 1.62e-07 | 40 | 28 | 4 | CID000071273 | |
| Drug | pyraclofos | 1.79e-07 | 106 | 28 | 5 | CID000093460 | |
| Drug | quindine | 2.33e-07 | 219 | 28 | 6 | CID000001065 | |
| Drug | phenytoin | 2.33e-07 | 219 | 28 | 6 | CID000001775 | |
| Drug | spiradoline | 2.88e-07 | 46 | 28 | 4 | CID000005620 | |
| Drug | indoxacarb | 3.73e-07 | 49 | 28 | 4 | CID000107720 | |
| Drug | bepridil | 4.25e-07 | 126 | 28 | 5 | CID000002351 | |
| Drug | AC1NSN3X | 5.55e-07 | 54 | 28 | 4 | CID005366189 | |
| Drug | tetradotoxin | 6.65e-07 | 428 | 28 | 7 | CID000020382 | |
| Drug | decamethrin | 8.83e-07 | 146 | 28 | 5 | ctd:C017180 | |
| Drug | zonisamide | 9.72e-07 | 62 | 28 | 4 | CID000005734 | |
| Drug | dofetilide | 1.04e-06 | 63 | 28 | 4 | CID000071329 | |
| Drug | resiniferatoxin | 1.25e-06 | 66 | 28 | 4 | CID000104826 | |
| Drug | moricizine | 1.34e-06 | 18 | 28 | 3 | CID000034632 | |
| Drug | amiodarone | 1.39e-06 | 160 | 28 | 5 | CID000002156 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 1.46e-06 | 2 | 28 | 2 | ctd:C502265 | |
| Drug | Hexylcaine | 1.46e-06 | 2 | 28 | 2 | DB00473 | |
| Drug | Ranolazine | 1.46e-06 | 2 | 28 | 2 | DB00243 | |
| Drug | Phenytoin | 1.46e-06 | 2 | 28 | 2 | DB00252 | |
| Drug | Flecainide | 1.46e-06 | 2 | 28 | 2 | DB01195 | |
| Drug | GBR 12909 | 1.50e-06 | 69 | 28 | 4 | CID000003455 | |
| Drug | T2755 | 1.68e-06 | 71 | 28 | 4 | CID000005514 | |
| Drug | gabapentin | 1.82e-06 | 169 | 28 | 5 | CID000003446 | |
| Drug | sotalol | 1.88e-06 | 73 | 28 | 4 | CID000005253 | |
| Drug | imide | 1.98e-06 | 74 | 28 | 4 | CID000443040 | |
| Drug | isofagomine | 2.09e-06 | 75 | 28 | 4 | CID000447607 | |
| Drug | diphenhydramine | 2.09e-06 | 75 | 28 | 4 | CID000003100 | |
| Drug | riluzole | 2.10e-06 | 174 | 28 | 5 | CID000005070 | |
| Drug | toluene | 2.16e-06 | 175 | 28 | 5 | CID000001140 | |
| Drug | bupropion | 2.85e-06 | 81 | 28 | 4 | CID000000444 | |
| Drug | QX-314 | 3.00e-06 | 82 | 28 | 4 | CID000003925 | |
| Drug | procainamide | 3.23e-06 | 190 | 28 | 5 | CID000004913 | |
| Drug | Multicide | 3.76e-06 | 25 | 28 | 3 | CID000024365 | |
| Drug | Dibucaine | 4.37e-06 | 3 | 28 | 2 | DB00527 | |
| Drug | DPI 201-106 | 5.35e-06 | 28 | 28 | 3 | CID000005190 | |
| Drug | encainide | 5.35e-06 | 28 | 28 | 3 | CID000048040 | |
| Drug | cyfluthrin | 5.96e-06 | 29 | 28 | 3 | ctd:C052570 | |
| Drug | trimethoprim | 6.36e-06 | 99 | 28 | 4 | CID000005578 | |
| Drug | oxcarbazepine | 6.61e-06 | 30 | 28 | 3 | CID000034312 | |
| Drug | isradipine | 6.61e-06 | 100 | 28 | 4 | CID000003784 | |
| Drug | Fospropofol | 8.74e-06 | 4 | 28 | 2 | DB06716 | |
| Drug | Propofol | 8.74e-06 | 4 | 28 | 2 | DB00818 | |
| Drug | NSC15627 | 9.72e-06 | 34 | 28 | 3 | CID000002073 | |
| Drug | sodium | 1.26e-05 | 944 | 28 | 8 | CID000000923 | |
| Drug | sipatrigine | 1.26e-05 | 37 | 28 | 3 | CID000060803 | |
| Drug | isoproterenol | 1.27e-05 | 669 | 28 | 7 | CID000003779 | |
| Drug | hydrochlorothiazide | 1.36e-05 | 120 | 28 | 4 | CID000003639 | |
| Drug | ranolazine | 1.48e-05 | 39 | 28 | 3 | CID000056959 | |
| Drug | bupivacaine | 1.60e-05 | 125 | 28 | 4 | CID000002474 | |
| Drug | triphosphoinositide | 1.87e-05 | 273 | 28 | 5 | CID009543520 | |
| Drug | potassium | 2.02e-05 | 1008 | 28 | 8 | CID000000813 | |
| Drug | clenbuterol | 2.64e-05 | 142 | 28 | 4 | CID000002783 | |
| Drug | salbutamol | 2.95e-05 | 146 | 28 | 4 | CID000002083 | |
| Drug | fluorocyclobutane | 3.05e-05 | 7 | 28 | 2 | CID011051569 | |
| Drug | procaine | 3.54e-05 | 153 | 28 | 4 | CID000004914 | |
| Drug | antipyrine | 3.74e-05 | 53 | 28 | 3 | CID000002206 | |
| Drug | 5,5'-dimethyl-2,2'-bipyridine | 4.07e-05 | 8 | 28 | 2 | CID000015664 | |
| Drug | Cocaine | 4.07e-05 | 8 | 28 | 2 | DB00907 | |
| Drug | dihydrochloride | 4.11e-05 | 159 | 28 | 4 | CID000070978 | |
| Drug | cyclaine | 5.22e-05 | 9 | 28 | 2 | CID000010770 | |
| Drug | methylglucamine | 6.00e-05 | 62 | 28 | 3 | CID000004049 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.93e-24 | 10 | 26 | 8 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.93e-24 | 10 | 26 | 8 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 5.42e-23 | 12 | 26 | 8 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.05e-12 | 163 | 26 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.43e-09 | 22 | 26 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 5.08e-08 | 9 | 26 | 3 | C3502809 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.73e-07 | 13 | 26 | 3 | C0751122 | |
| Disease | Romano-Ward Syndrome | 3.38e-07 | 16 | 26 | 3 | C0035828 | |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 7.47e-07 | 2 | 26 | 2 | C4551549 | |
| Disease | B Virus Infection | 2.24e-06 | 3 | 26 | 2 | C0037140 | |
| Disease | Benign familial infantile epilepsy | 2.24e-06 | 3 | 26 | 2 | cv:C5575231 | |
| Disease | Postherpetic neuralgia | 2.24e-06 | 3 | 26 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 2.24e-06 | 3 | 26 | 2 | C0019372 | |
| Disease | PAROXYSMAL EXTREME PAIN DISORDER | 2.24e-06 | 3 | 26 | 2 | C1833661 | |
| Disease | Primary Erythermalgia | 2.24e-06 | 3 | 26 | 2 | C0014805 | |
| Disease | Epilepsy | 2.47e-06 | 109 | 26 | 4 | C0014544 | |
| Disease | Brugada ECG Pattern | 4.47e-06 | 4 | 26 | 2 | C1721096 | |
| Disease | Familial benign neonatal epilepsy | 1.12e-05 | 6 | 26 | 2 | C0220669 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.56e-05 | 7 | 26 | 2 | C0020075 | |
| Disease | Seizure, Febrile, Simple | 1.56e-05 | 7 | 26 | 2 | C0149886 | |
| Disease | long QT syndrome (is_implicated_in) | 1.56e-05 | 7 | 26 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | Seizure, Febrile, Complex | 1.56e-05 | 7 | 26 | 2 | C0751057 | |
| Disease | electrocardiography, PR interval | 1.56e-05 | 7 | 26 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | Congenital Pain Insensitivity | 1.56e-05 | 7 | 26 | 2 | C0002768 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.08e-05 | 8 | 26 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.08e-05 | 8 | 26 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.08e-05 | 8 | 26 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 2.08e-05 | 8 | 26 | 2 | C0438414 | |
| Disease | Ventricular Fibrillation | 2.08e-05 | 8 | 26 | 2 | C0042510 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.08e-05 | 8 | 26 | 2 | C0751120 | |
| Disease | Myoclonic Absence Epilepsy | 2.08e-05 | 8 | 26 | 2 | C0393703 | |
| Disease | Febrile Convulsions | 2.68e-05 | 9 | 26 | 2 | C0009952 | |
| Disease | Myoclonic Epilepsy | 2.68e-05 | 9 | 26 | 2 | C0014550 | |
| Disease | supraventricular ectopy | 2.68e-05 | 9 | 26 | 2 | EFO_0009277 | |
| Disease | Epilepsy, Myoclonic, Infantile | 3.35e-05 | 10 | 26 | 2 | C0917800 | |
| Disease | Congenital long QT syndrome | 4.09e-05 | 11 | 26 | 2 | cv:C1141890 | |
| Disease | Myoclonic Astatic Epilepsy | 4.09e-05 | 11 | 26 | 2 | C0393702 | |
| Disease | Long QT Syndrome | 4.09e-05 | 11 | 26 | 2 | C0023976 | |
| Disease | Long QT syndrome | 4.90e-05 | 12 | 26 | 2 | cv:C0023976 | |
| Disease | Epilepsy, Cryptogenic | 5.14e-05 | 82 | 26 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 5.14e-05 | 82 | 26 | 3 | C0751111 | |
| Disease | Aura | 5.14e-05 | 82 | 26 | 3 | C0236018 | |
| Disease | Brugada Syndrome 1 | 5.79e-05 | 13 | 26 | 2 | C4551804 | |
| Disease | T wave morphology measurement | 6.75e-05 | 14 | 26 | 2 | EFO_0008398 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 6.75e-05 | 14 | 26 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 7.48e-05 | 93 | 26 | 3 | C1535926 | |
| Disease | MMR-related febrile seizures | 7.78e-05 | 15 | 26 | 2 | EFO_0006519 | |
| Disease | P wave duration | 7.78e-05 | 15 | 26 | 2 | EFO_0005094 | |
| Disease | Neuralgia, Supraorbital | 8.89e-05 | 16 | 26 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 8.89e-05 | 16 | 26 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 8.89e-05 | 16 | 26 | 2 | C0423711 | |
| Disease | Neuralgia | 8.89e-05 | 16 | 26 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 8.89e-05 | 16 | 26 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 8.89e-05 | 16 | 26 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 8.89e-05 | 16 | 26 | 2 | C0751373 | |
| Disease | Nerve Pain | 8.89e-05 | 16 | 26 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 8.89e-05 | 16 | 26 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 8.89e-05 | 16 | 26 | 2 | C0042656 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 8.89e-05 | 16 | 26 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.13e-04 | 18 | 26 | 2 | HP_0002373 | |
| Disease | Brugada syndrome | 1.26e-04 | 19 | 26 | 2 | MONDO_0015263 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 1.71e-04 | 22 | 26 | 2 | C1843687 | |
| Disease | Brugada Syndrome (disorder) | 2.04e-04 | 24 | 26 | 2 | C1142166 | |
| Disease | cardiovascular age measurement | 2.99e-04 | 29 | 26 | 2 | EFO_0803380 | |
| Disease | Paroxysmal atrial fibrillation | 3.45e-04 | 156 | 26 | 3 | C0235480 | |
| Disease | familial atrial fibrillation | 3.45e-04 | 156 | 26 | 3 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.45e-04 | 156 | 26 | 3 | C2585653 | |
| Disease | Atrial Fibrillation | 3.71e-04 | 160 | 26 | 3 | C0004238 | |
| Disease | heart function measurement | 4.12e-04 | 34 | 26 | 2 | EFO_0004311 | |
| Disease | QRS complex, QRS duration | 7.22e-04 | 45 | 26 | 2 | EFO_0005054, EFO_0005055 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 8.56e-04 | 49 | 26 | 2 | EFO_0021897 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MYLIFYIENMQYLLI | 1076 | Q8N139 | |
| VNVLILYYAFLMEYI | 36 | O95424 | |
| YYVINVEFPVVTLYM | 456 | Q9H4D0 | |
| VVILFYGAAVYTYML | 251 | Q6IEZ7 | |
| VDAENFYYVILYLMV | 41 | Q9Y6J6 | |
| LIYFLFLLYYMVVQG | 2191 | Q7Z442 | |
| VVILFYGAAVYTYML | 251 | Q8NH02 | |
| YQILTDFDIRFYMYE | 126 | P19784 | |
| YKYFQYLTFMVLVFI | 241 | A8MYB1 | |
| EVNLYMYLYFVIFII | 1266 | P35499 | |
| YLYVAILIFFLAYVV | 1966 | Q9NTG1 | |
| EYNLYMYIYFVIFII | 1441 | Q14524 | |
| LYMYIYFVVFIIFGS | 1431 | Q15858 | |
| NLYMYLYFVIFIIFG | 1441 | Q9NY46 | |
| IYYNMIIAYVLFYLF | 131 | Q99884 | |
| SLYMYLYFVIFIIFG | 1456 | P35498 | |
| LYFLVFVFIYLMSYI | 1076 | O94911 | |
| YFIFEYMKENLYQLI | 76 | Q9UPZ9 | |
| NVYMYLYFVIFIIFG | 1391 | Q9Y5Y9 | |
| IYLLVALFIQYINIY | 81 | Q9NV64 | |
| MLVLLYYFYDLLVYV | 236 | Q8TCT7 | |
| NLYMYLYFVIFIIFG | 1446 | Q99250 | |
| VIYTMLVLIFIYTYQ | 741 | Q9H5I5 | |
| QSMLLEIIFLYYAYF | 211 | Q5SRE5 | |
| DNIYMYIYFVIFIIF | 1436 | Q9UQD0 | |
| LFSLGYMYYVFLQEV | 146 | Q8IYP9 | |
| ISINYYFMFLYVLES | 641 | Q5TAH2 | |
| LLYVYLLYLFFRMAQ | 506 | O76024 |